Literature DB >> 29353495

Neurocognitive functioning of HIV positive children attending the comprehensive care clinic at Kenyatta national hospital: exploring neurocognitive deficits and psychosocial risk factors.

Otsetswe Musindo1, Paul Bangirana2, Pius Kigamwa1, Roselyne Okoth1, Manasi Kumar1.   

Abstract

Children and adolescents are affected in different ways by HIV/AIDS. Neurocognitive deficits are one of the most significant long term effects on HIV infected children and adolescents. Several factors are thought to influence cognitive outcomes and this include immune status, Highly Active Antiretroviral Therapy (HAART), education and social support. The aim of the study was to assess the neurocognitive function of HIV infected children and adolescents and correlate it with psychosocial factors. A cross sectional study was carried out involving a sample of 90 children living with HIV between 8 and 15 years (M = 11.38, SD = 2.06) attending Comprehensive Care Clinic (CCC) at Kenyatta National Hospital (KNH). Samples were selected by using purposive sample technique. Kaufman Assessment Battery for Children-Second Edition was used to assess cognitive function and psychosocial issues were assessed using HEADS-ED. Data was analyzed using SPSS v23 and independent T-tests, Pearson's correlation and linear regression were used. The prevalence of neurocognitive deficits among HIV positive children attending CCC at KNH was 60% with neurocognitive performance of 54 children being at least 2SD below the mean based on the KABC-II scores. There was no significant correlation between mental processing index and CD4 count (Pearson's rho =  -0.01, p = 0.39). There was no significant association between Mental Processing Index and viral load (p = 0.056) and early ARV initiation (0.27). Using the HEADS-ED, risks factors related to education (β =  -5.67, p = 0.02) and activities and peer support (β =  -9.1, p = 0.002) were significantly associated with poor neurocognitive performance. Neurocognitive deficits are prevalent among HIV positive children attending CCC-KNH. This extent of the deficits was not associated with low CD4 count, high viral load or early initiation in HIV care. However, poor school performance and problem with peers was associated with poor neurocognitive performance.

Entities:  

Keywords:  Children and adolescents; Nairobi; neurocognitive assessment; psychosocial difficulties

Mesh:

Year:  2018        PMID: 29353495      PMCID: PMC6441111          DOI: 10.1080/09540121.2018.1426829

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  11 in total

1.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

2.  Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV.

Authors:  Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

3.  The HEADS-ED: a rapid mental health screening tool for pediatric patients in the emergency department.

Authors:  Mario Cappelli; Clare Gray; Roger Zemek; Paula Cloutier; Allison Kennedy; Elizabeth Glennie; Guy Doucet; John S Lyons
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

4.  Early antiretroviral therapy improves neurodevelopmental outcomes in infants.

Authors:  Barbara Laughton; Morna Cornell; Debbie Grove; Martin Kidd; Priscilla E Springer; Els Dobbels; Anita J van Rensburg; Avy Violari; Abdel G Babiker; Shabir A Madhi; Patrick Jean-Philippe; Diana M Gibb; Mark F Cotton
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

5.  Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.

Authors:  Rita J Jeremy; Soyeon Kim; Molly Nozyce; Sharon Nachman; Kenneth McIntosh; Stephen I Pelton; Ram Yogev; Andrew Wiznia; George M Johnson; Paul Krogstad; Kenneth Stanley
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

6.  Neurocognitive function profile in HIV-infected school-age children.

Authors:  Sanneke Koekkoek; Leo M J de Sonneville; Tom F W Wolfs; Rob Licht; Sibyl P M Geelen
Journal:  Eur J Paediatr Neurol       Date:  2007-10-18       Impact factor: 3.140

7.  Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children.

Authors:  Danstan Bagenda; Annette Nassali; Israel Kalyesubula; Becky Sherman; Dennis Drotar; Michael J Boivin; Karen Olness
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

8.  A Randomized Controlled Trial to Evaluate if Computerized Cognitive Rehabilitation Improves Neurocognition in Ugandan Children with HIV.

Authors:  Michael J Boivin; Noeline Nakasujja; Alla Sikorskii; Robert O Opoka; Bruno Giordani
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-02       Impact factor: 2.205

9.  Impact of sociodemographic factors on cognitive function in school-aged HIV-infected Nigerian children.

Authors:  Gbemisola O Boyede; Foluso Ea Lesi; Veronica C Ezeaka; Charles S Umeh
Journal:  HIV AIDS (Auckl)       Date:  2013-07-15

10.  Socioeconomic predictors of cognition in Ugandan children: implications for community interventions.

Authors:  Paul Bangirana; Chandy C John; Richard Idro; Robert O Opoka; Justus Byarugaba; Anne M Jurek; Michael J Boivin
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more
  4 in total

1.  Significant differences between verbal and non-verbal intellectual scales on a perinatally HIV-infected cohort: from pediatrics to young adults.

Authors:  C García-Navarro; S Jimenez de Ory; C Velo Higueras; B Zamora; L Prieto; J T Ramos; M L Navarro; L Escosa-García; R Jurado-Barba; Dolores Falcón; David Moreno; M I González-Tomé
Journal:  Heliyon       Date:  2020-04-25

2.  Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study.

Authors:  Damalie Nalwanga; Victor Musiime; Paul Bangirana; Erika Phelps Nishiguchi; Andrew Kiggwe; Titus Ssesanga; John M Ssenkusu; Philippa Musoke; Sarah E Cusick
Journal:  BMC Pediatr       Date:  2021-04-26       Impact factor: 2.125

3.  Positive and Healthy Living Program Manual Development for Young People Living With HIV at the Comprehensive Care Center at the Kenyatta National Hospital: An Open Pilot Implementation Trial.

Authors:  Judy Machuka; Grace Nduku Wambua; Otsetswe Musindo; David Bukusi; Violet Okech; Peter Muiruri; Rachel Maina; Nelly Opiyo; Pauline Ng'ang'a; Manasi Kumar
Journal:  Front Psychiatry       Date:  2020-11-17       Impact factor: 4.157

Review 4.  Neurocognitive deficits and socioeconomic risk factors among children and adolescents living with HIV in sub-Saharan Africa: a systematic review.

Authors:  Otsetswe Musindo; Lydiah Krabbendam; Joan Mutahi; Miguel Pérez García; Paul Bangirana; Manasi Kumar
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2022-04-27       Impact factor: 7.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.